Found 46 matching trials
Low-dose Lenalidomide for Non-severe COVID-19 Treatment Trial PHASE4 Double-blind randomized controlled clinical trial (RCT) of low-dose lenalid...
Show More Location
Hospital Universitario de Getafe
Learn More & Join Trial
Efficacy of Eltrombopag Plus Lenalidomide Combination Therapy in Patients With IPSS Low and Intermediate-risk Myelodysplastic Syndrome With Isolated del5q PHASE2 Myelodysplastic syndromes (MDS) prevail in elderly patients and are charact...
Show More Learn More & Join Trial
Tafasitamab + Lenalidomide + R-CHOP Versus R-CHOP in Newly Diagnosed High-intermediate and High Risk DLBCL Patients PHASE3 This is a phase 3, multicenter, randomized, double-blind, placebo-controlle...
Show More Status
Active Not Recruiting
Location
MorphoSys Research Site
Learn More & Join Trial
Myeloma XIV: Frailty-adjusted Therapy in Transplant Non-Eligible Patients With Newly Diagnosed Multiple Myeloma PHASE3 Trial Title:
FiTNEss (UK-MRA Myeloma XIV) - Frailty-adjusted therapy in Tr...
Show More Location
Aberdeen Royal Infirmary
Learn More & Join Trial
A Study to Assess the Efficacy, Safety, Pharmacodynamics, and Pharmacokinetics of Tazemetostat in Combination With Lenalidomide Plus Rituximab Versus Placebo in Combination With Lenalidomide Plus Rituximab in Adult Patients at Least 18 Years of Age With Relapsed/Refractory Follicular Lymphoma. PHASE3 The participants of this study would have relapsed/refractory follicular ly...
Show More Status
Active Not Recruiting
Location
Southern Cancer Center
Learn More & Join Trial
S0232 Dexamethasone With or Without Lenalidomide in Treating Patients With Previously Untreated Stage I, Stage II, or Stage III Multiple Myeloma PHASE3 RATIONALE: Drugs used in chemotherapy such as dexamethasone use different w...
Show More Location
William Beaumont Hospital - Royal Oak Campus
Learn More & Join Trial
Study to Evaluate the Efficacy and Safety of Lenalidomide in the Treatment of Painful Lumbar Radiculopathy PHASE2 The purpose of this multicenter, double-blind, placebo-controlled study is ...
Show More Location
Arizona Research Center
Learn More & Join Trial
A Study to Compare MPR With MP in Newly Diagnosed Multiple Myeloma Subjects 65 Years Old or Older. PHASE3 The purpose of this study is to determine whether lenalidomide is safe and ...
Show More Location
Hematology Oncology Clinics of Australia, Level 5, Mater Medical Centre
Learn More & Join Trial
Treatment Optimization in Patients With Untreated Multiple Myeloma PHASE2 This is a multicenter, randomized, blinded, 2-arm phase IIb trial that will...
Show More Location
Charité - Campus Benjamin Franklin Medizinische Klinik II
Learn More & Join Trial
CC-5013 Plus Dexamethasone Versus Dexamethasone Alone in Previously Treated Subjects With Multiple Myeloma PHASE3 Randomized subjects will receive CC-5013 plus high-dose dexamethasone or pl...
Show More Location
Clinical Research Consultants, Inc.
Learn More & Join Trial